H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α₅β₁?

Figure 7

Comparison of the biodistribution data with data from blocking of [¹⁸F]FProp--OH uptake by coinjection of 200 μg or 300 μg H--OH per mouse in nude mice bearing DU145 human prostate and biodistribution in M21-bearing nude mice (which do not express α ₅β ₁).